Trial NCT04996004

View at ClinicalTrials.gov 
Org. Study IDs: TTI-621-03
Secondary IDs: C4961003

Last trial update was posted on 2024-04-11

MeSH Interventions

Doxorubicin

MeSH Conditions

Leiomyosarcoma

Other Conditions


Stopping Reasons

Pfizer decided to terminate the study for administrative reasons. The termination was neither due to safety concerns nor a request from the regulatory authorities.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID